Jason Duncan, Chief Legal Officer and GC at ALBIREO PHARMA, INC. (ALBO), sold 655 shares at $33.40 ($22K) on 2022-04-25, disclosed to the SEC on 2022-04-25.
Scheduled sale ($22k) by Chief Legal Officer and GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.93 | 103 | $3K | 15.6% |
| 2 | $33.07 | 240 | $8K | 36.5% |
| 3 | $33.40 | 91 | $3K | 14.0% |
| 4 | $33.44 | 221 | $7K | 34.0% |
| Total | $33.22 avg | 655 | $22K | 100% |
| Filing → |
| ALBO | SELL | 2022-10-25 | $13K | — | Filing → |
| ALBO | SELL | 2022-07-25 | $16K | — | Filing → |
| ALBO | SELL | 2022-01-25 | $42K | — | Filing → |